1. Home
  2. FATE vs SKYX Comparison

FATE vs SKYX Comparison

Compare FATE & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • SKYX
  • Stock Information
  • Founded
  • FATE 2007
  • SKYX 2004
  • Country
  • FATE United States
  • SKYX United States
  • Employees
  • FATE N/A
  • SKYX N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • SKYX Building Products
  • Sector
  • FATE Health Care
  • SKYX Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • FATE 116.5M
  • SKYX 127.2M
  • IPO Year
  • FATE 2013
  • SKYX 2022
  • Fundamental
  • Price
  • FATE $0.96
  • SKYX $1.26
  • Analyst Decision
  • FATE Hold
  • SKYX
  • Analyst Count
  • FATE 6
  • SKYX 0
  • Target Price
  • FATE $3.30
  • SKYX N/A
  • AVG Volume (30 Days)
  • FATE 1.4M
  • SKYX 326.5K
  • Earning Date
  • FATE 11-11-2025
  • SKYX 11-11-2025
  • Dividend Yield
  • FATE N/A
  • SKYX N/A
  • EPS Growth
  • FATE N/A
  • SKYX N/A
  • EPS
  • FATE N/A
  • SKYX N/A
  • Revenue
  • FATE $8,470,000.00
  • SKYX $89,028,500.00
  • Revenue This Year
  • FATE N/A
  • SKYX $13.49
  • Revenue Next Year
  • FATE N/A
  • SKYX $31.75
  • P/E Ratio
  • FATE N/A
  • SKYX N/A
  • Revenue Growth
  • FATE N/A
  • SKYX 5.71
  • 52 Week Low
  • FATE $0.66
  • SKYX $0.80
  • 52 Week High
  • FATE $4.20
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • FATE 40.20
  • SKYX 60.95
  • Support Level
  • FATE $0.93
  • SKYX $1.13
  • Resistance Level
  • FATE $1.08
  • SKYX $1.22
  • Average True Range (ATR)
  • FATE 0.06
  • SKYX 0.06
  • MACD
  • FATE -0.01
  • SKYX 0.00
  • Stochastic Oscillator
  • FATE 11.22
  • SKYX 70.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: